Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma

Ward, 2001, Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma, Genes Chromosomes Cancer, 32, 59, 10.1002/gcc.1167 Carter, 2002, Genetic abnormalities detected in ependymomas by comparative genomic hybridisation, Br J Cancer, 86, 929, 10.1038/sj.bjc.6600180 Ransom, 1992, Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas, Genes Chromosomes Cancer, 5, 348, 10.1002/gcc.2870050411 Grill, 2002, Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas, Cancer Genet Cytogenet, 136, 121, 10.1016/S0165-4608(02)00516-2 Jeuken, 2002, Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH, J Pathol, 197, 238, 10.1002/path.1086 Dyer, 2002, Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups, Am J Pathol, 161, 2133, 10.1016/S0002-9440(10)64491-4 Belinsky, 2004, Gene-promoter hypermethylation as a biomarker in lung cancer, Nat Rev Cancer, 4, 707, 10.1038/nrc1432 Herman, 2003, Gene silencing in cancer in association with promoter hypermethylation, N Engl J Med, 349, 2042, 10.1056/NEJMra023075 Knudson, 2000, Chasing the cancer demon, Annu Rev Genet, 34, 1, 10.1146/annurev.genet.34.1.1 Myohanen, 1998, Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia, Cancer Res, 58, 591 Baylin, 2000, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, Trends Genet, 16, 168, 10.1016/S0168-9525(99)01971-X Dong, 2003, Epigenetic inactivation of RASSF1A in head and neck cancer, Clin Cancer Res, 9, 3635 Yang, 2002, 5-aza-2′-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells, Anticancer Res, 22, 2753 Alonso, 2003, Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas, Cancer Genet Cytogenet, 144, 134, 10.1016/S0165-4608(02)00928-7 Mitelman, 1991 Rogatto, 1993, Chromosomes in the genesis and progression of ependymomas, Cancer Genet Cytogenet, 69, 146, 10.1016/0165-4608(93)90093-2 de Fraipont, 2005, Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?, Lung Cancer, 50, 199, 10.1016/j.lungcan.2005.05.019 Agarwal, 2004, Choroid plexus papilloma associated with developmental delay, Indian J Pediatr, 71, 763, 10.1007/BF02730671 Baylin, 2001, Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer, Hum Mol Genet, 10, 687, 10.1093/hmg/10.7.687 Topaloglu, 2004, Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer, Clin Cancer Res, 10, 2284, 10.1158/1078-0432.CCR-1111-3 Chan, 2003, Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients, Int J Cancer, 104, 611, 10.1002/ijc.10971 Wong, 2004, Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia, Clin Cancer Res, 10, 994, 10.1158/1078-0432.CCR-0378-3 Alonso, 2004, Aberrant CpG island methylation of multiple genes in ependymal tumors, J Neurooncol, 67, 159, 10.1023/B:NEON.0000021862.41799.f7 Pu, 2003, Methylation profiling of benign and malignant breast lesions and its application to cytopathology, Mod Pathol, 16, 1095, 10.1097/01.MP.0000095782.79895.E2 Pekarsky, 2002, FHIT: from gene discovery to cancer treatment and prevention, Lancet Oncol, 3, 748, 10.1016/S1470-2045(02)00931-2 Hesson, 2004, Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas, Oncogene, 23, 2408, 10.1038/sj.onc.1207407 Costello, 1996, Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation, Cancer Res, 56, 2405 Ueki, 1996, CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated, Cancer Res, 56, 150 Rousseau, 2003, CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours, Neuropathol Appl Neurobiol, 29, 574, 10.1046/j.0305-1846.2003.00505.x Sevenet, 1999, Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations, Hum Mol Genet, 8, 2359, 10.1093/hmg/8.13.2359 Knudson, 2001, Two genetic hits (more or less) to cancer, Nat Rev Cancer, 1, 157, 10.1038/35101031 Eads, 2001, Epigenetic patterns in the progression of esophageal adenocarcinoma, Cancer Res, 61, 3410 Gonzalez-Gomez, 2003, Aberrant methylation of multiple genes in neuroblastic tumours: relationship with MYCN amplification and allelic status at 1p, Eur J Cancer, 39, 1478, 10.1016/S0959-8049(03)00312-5 Zochbauer-Muller, 2001, Aberrant promoter methylation of multiple genes in non-small cell lung cancers, Cancer Res, 61, 249 Zochbauer-Muller, 2001, 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer, Cancer Res, 61, 3581 van Noesel, 2003, Clustering of hypermethylated genes in neuroblastoma, Genes Chromosomes Cancer, 38, 226, 10.1002/gcc.10278 Kino, 2001, Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma, Genes Cells, 6, 441, 10.1046/j.1365-2443.2001.00432.x Virmani, 2000, Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas, J Natl Cancer Inst, 92, 1303, 10.1093/jnci/92.16.1303 van Noesel, 2002, Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation, Cancer Res, 62, 2157